Digital health and wellness company Hims & Hers is investing more than $200 million to expand its operations in New Albany ...
Medical Device Network on MSN
Hims & Hers Health signs agreement to acquire YourBio Health
The transaction closure is anticipated in early 2026, contingent on regulatory approvals and other customary conditions.
Hims & Hers Health (HIMS) has entered into an agreement to acquire YourBio Health, a Boston-based maker of capillary whole blood sampling technology.
Shares of Hims & Hers are trending Thursday morning. The San Francisco-based telehealth company announced an international expansion.
What To Know: While Hims & Hers doesn’t manufacture the GLP-1 drugs, a class of medications that help manage Type 2 diabetes and obesity, like Eli Lilly’s Zepbound and Novo Nordisk’s Ozempic, it sells ...
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its bumpy ride over recent months. The San Francisco, CA-based health and ...
Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market and supporting its $6.5 billion 2030 revenue target. Recent product launches, ...
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Hims & Hers Health, Inc. (HIMS) reports results for the quarter ended September 2025. While this widely-known ...
Supported by strong balance sheet, program provides flexibility for Company to capitalize on valuation disconnects over the next three years SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc.
Health and wellness platform Hims & Hers Health (NYSE: HIMS) is following WeightWatchers’ lead in offering perimenopause and menopause treatment plans. Hers treatment plans may include prescription ...
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to ...
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback